Dorsey Wright & Associates’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-30,204
Closed -$2.76M 305
2020
Q4
$2.76M Buy
30,204
+2,692
+10% +$223K 0.41% 78
2020
Q3
$2.2M Sell
27,512
-13,731
-33% -$1.07M 0.4% 80
2020
Q2
$2.85M Buy
+41,243
New +$2.93M 0.58% 52
2020
Q1
Sell
-27,114
Closed -$2.11M 296
2019
Q4
$2.11M Sell
27,114
-705
-3% -$55K 0.7% 57
2019
Q3
$2.04M Sell
27,819
-207
-0.7% -$14.5K 0.51% 83
2019
Q2
$1.73M Sell
28,026
-1,482
-5% -$89.6K 0.42% 103
2019
Q1
$1.88M Buy
+29,508
New +$1.68M 0.46% 97
2016
Q4
Sell
-127,200
Closed -$5.11M 145
2016
Q3
$5.11M Buy
127,200
+7,107
+6% +$268K 2.43% 15
2016
Q2
$3.99M Sell
120,093
-12,867
-10% -$440K 2.12% 15
2016
Q1
$3.91M Sell
132,960
-2,550
-2% -$70.4K 2.07% 13
2015
Q4
$3.57M Buy
135,510
+2,526
+2% +$65.6K 1.83% 15
2015
Q3
$3.15M Buy
132,984
+63,390
+91% +$1.53M 1.67% 14
2015
Q2
$1.55M Sell
69,594
-12
-0% -$271 0.75% 40
2015
Q1
$1.65M Sell
69,606
-300
-0.4% -$6.73K 0.76% 38
2014
Q4
$1.48M Buy
+69,906
New +$1.4M 0.68% 38

Other funds holding EW

Dorsey Wright & Associates's EW Position: Q1 2021 in Review

Dorsey Wright & Associates sold out of Edwards Lifesciences (EW) in Q1 2021, closing a stake of 30,204 shares — an estimated $2.76M sold.

Dorsey Wright & Associates first reported a position in EW in Q4 2014 and held it in 15 quarters. The position peaked at $5.11M in Q3 2016. 1,143 funds tracked by Wall St. Rank hold EW as of Q1 2021.

  • Dorsey Wright & Associates reported no remaining Edwards Lifesciences position as of Q1 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 30,204 Edwards Lifesciences shares in Q1 2021, an estimated $2.76M.
  • Dorsey Wright & Associates first reported a position in Edwards Lifesciences in Q4 2014 and held it in 15 quarters.
  • Dorsey Wright & Associates's Edwards Lifesciences position peaked at $5.11M in Q3 2016.
  • 1,143 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2021.

Based on Dorsey Wright & Associates's 13F filing for Q1 2021, filed 27 Apr 2021.